Alliance announces FDA Acceptance of Supplemental Biologics License Application supported by results from the Phase III ATOMIC Trial for Patients with Stage III dMMR Colon Cancer
Business Announcement
Updates every hour. Last Updated: 29-Oct-2026 07:15 ET (29-Oct-2026 11:15 GMT/UTC)